Блог
MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us
A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be nex…
Jun 8, 2026
Stem Cells and Your Gut Microbiome: The Hidden Connection That Changes Everything
Your gut bacteria directly control how well your stem cells work. Here’s what every patient should know before treatment.
Jun 1, 2026
Pediatric Applications of Stem Cell Therapy
Stem cell therapy holds immense promise for treating rare diseases in children, offering hope for conditions that are often difficult to manage with conventional treatments. Mesenchymal stem cells (MSCs) are particularly…
Jun 2, 2025
Stem Cells in 2024: From Lab to Clinic
Stem cell research in 2024 has seen remarkable progress, with several studies translating lab discoveries into potential clinical applications. This article explores how these advancements are moving from the research be…
Jan 8, 2025
The Role of Microbiome in Immunotherapy for Cancer
Immunotherapy has revolutionized cancer treatment, but its effectiveness can be significantly influenced by the patient’s microbiome. Recent studies have highlighted the intricate relationship between the gut microbiota …
Dec 18, 2024
Revolutionizing Cancer Treatment with CIK Cells
When it comes to modern medicine, advancements in cancer treatment and immune system rejuvenation are among the most exciting fields of study. One such breakthrough involves Cytokine-Induced Killer (CIK) cells. These spe…
Oct 7, 2024
Hematopoietic Stem Cell Transplantation: An Advanced Treatment Option for Blood-Related Diseases
Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves the transplantation of stem cells that are capable of forming blood cells. This advanced treatment option is used to treat various blood…
Apr 20, 2023
Stem Cell Transplant: A Breakthrough in Medical Science
Stem cell transplant is a medical procedure that involves the transfer of stem cells from one person to another. This treatment is designed to replace damaged or diseased cells with healthy cells, leading to a new and im…
Feb 6, 2023
Спящие клетки: недавно обнаруженная фаза покоя стволовых клеток может усыпить опухоли головного мозга
Исследователи в области биомедицинской инженерии разработали новый инструмент для классификации клеток, который рассматривает жизненный цикл нейроэпителиальных стволовых клеток с более высоким разрешением, что привело к открытию и исследованию новой фазы покоя, названной Neural G0. Эти знания могут помочь ученым лучше понять глиомные опухоли головного мозга и разработать новые методы лечения.
Aug 2, 2021
Идентификация маркеров стволовых клеток рака печени с использованием сравнительного анализа общедоступных наборов данных
National Institutes of Health and other agencies are funding high-throughput genomics and transcriptomics (‘omics) experiments that deposit digital samples of data into the public domain at a rapidly increasing scale. 1 , 2 The importance of these digital samples of data is further illustrated by the growing number of linked peer-reviewed publications that demonstrate its scientific value. 3 , 4 Investigations of cancer stem cells (CSC) is a promising research avenue, which leads to the generation of large volumes of unique data. There is growing evidence implicating CSCs in causing therapeutic resistance, tumor recurrence, and metastasis. It is known that these cells possess stem-like properties/functions and represent a critical subset within the tumor mass that is responsible for perpetuating the tumor, even in post-therapy patients. CSCs share similar properties with normal stem cells, including the ability to self-renew and differentiate that gives rise to heterogeneous cancer cells, making up the bulk of the tumor. 5
Jul 5, 2021
Спроектированные натуральные клетки-киллеры могут уничтожать стволовые клетки рака глиобластомы
Deleting the TFG-β receptor in NK cells overcame immune suppression and enabled anti-tumor activity in preclinical models. Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling protein, which blocks NK cell activity. Deleting the TFG-β receptor in NK cells, however, rendered them resistant to this immune suppression and enabled their anti-tumor activity.
Jun 19, 2021
Page 1 of 1 — 11 posts